Document Detail


Influence of graft rejection on incidence of accelerated graft coronary artery disease: a new approach to analysis.
MedLine Citation:
PMID:  8312304     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Conflicting data exist on the role of graft rejection as a risk factor for later development of accelerated graft coronary artery disease. We analyzed 126 consecutive heart transplant recipients treated with cyclosporine-based immunosuppressive regimens and devised an arbitrary method to incorporate the number, duration, and severity of myocardial rejection episodes during the first postoperative year, resulting in a rejection score for each patient. We then correlated the later incidence (mean follow-up, 4 years) of angiographic accelerated graft coronary artery disease with this rejection score and with its components: number, duration, and severity of rejection; number and duration of untreated rejection; and incidence and duration of delayed rejection therapy. Accelerated graft coronary artery disease developed in 60 patients (48%). The rejection score was 96.7 for patients in the "no accelerated graft coronary artery disease" group and 110.4 for those in the "accelerated graft coronary artery disease" group (p = NS). No significant difference was noted between patients with and without disease in any of the other seven rejection parameters analyzed, and no significant difference in time to occurrence of disease was noted between groups divided at the median rejection score. Donor age was older and fasting triglyceride blood level was higher in patients with accelerated graft coronary artery disease than in those without disease. All other clinical characteristics, including HLA mismatches, ischemic time, blood pressure, lipid profile, and drug therapy, did not differ between the two groups.(ABSTRACT TRUNCATED AT 250 WORDS)
Authors:
S Z Gao; J S Schroeder; S A Hunt; H A Valantine; I R Hill; E B Stinson
Related Documents :
9213024 - Treatment of thrombotic saphenous vein bypass grafts using local urokinase infusion the...
16614584 - Does fast-track treatment lead to a decrease of intensive care unit and hospital length...
8783994 - North american experience with the perma-flow prosthetic coronary graft.
10409524 - Good outcomes from cardiac surgery in the over 70s.
2492324 - Effect of cutaneous nitroglycerin patches on coronary artery diameter: issues concernin...
11220454 - Preventing sudden death in coronary cardiomyopathy: implantable defibrillators lead the...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation     Volume:  12     ISSN:  1053-2498     ISO Abbreviation:  J. Heart Lung Transplant.     Publication Date:    1993 Nov-Dec
Date Detail:
Created Date:  1994-03-23     Completed Date:  1994-03-23     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  9102703     Medline TA:  J Heart Lung Transplant     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1029-35     Citation Subset:  IM    
Affiliation:
Division of Cardiovascular Medicine, Stanford University School of Medicine, CA 94305.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Adolescent
Adult
Coronary Disease / etiology*
Cyclosporine / administration & dosage
Female
Graft Rejection* / diagnosis
Heart Transplantation / adverse effects*
Humans
Male
Middle Aged
Time Factors
Chemical
Reg. No./Substance:
59865-13-3/Cyclosporine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Static left latissimus dorsi cardiomyoplasty: effect on left ventricular function.
Next Document:  Amlodipine reduces graft coronary artery disease in rat heterotopic cardiac allografts.